Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Daga

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Frontiers in Pharmacology|September 7, 2018
Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell ViabilityFederica Barbieri, Roberto Würth, Alessandra Pattarozzi, et al.
Haematologica|May 21, 2009
Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasmsDavide Bagnara, Adalberto Ibatici, Mirko Corselli, et al.
Oncotarget|May 28, 2016
Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cellsAlessandro Corsaro, Adriana Bajetto, Stefano Thellung, et al.
Oncotarget|November 1, 2014
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion currentMarta Gritti, Roberto Würth, Marina Angelini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
NK cells recognize and kill human glioblastoma cells with stem cell-like propertiesRoberta Castriconi, Antonio Daga, Alessandra Dondero, et al.
Scientific Reports|March 4, 2018
Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor EffectsSara Baldassari, Agnese Solari, Guendalina Zuccari, et al.
Experimental Cell Research|January 7, 2018
In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivityMonica Gatti, Agnese Solari, Alessandra Pattarozzi, et al.
Oncotarget|August 25, 2015
New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALKDaniela Di Paolo, D Yang, Fabio Pastorino, et al.
Oncotarget|December 29, 2016
The inhibition of 45A ncRNA expression reduces tumor formation, affecting tumor nodules compactness and metastatic potential in neuroblastoma cellsIlaria Penna, Arianna Gigoni, Delfina Costa, et al.
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of AktRoberto Würth, Alessandra Pattarozzi, Monica Gatti, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Frontiers in Pharmacology|September 7, 2018
Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell ViabilityFederica Barbieri, Roberto Würth, Alessandra Pattarozzi, et al.
Haematologica|May 21, 2009
Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasmsDavide Bagnara, Adalberto Ibatici, Mirko Corselli, et al.
Oncotarget|May 28, 2016
Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cellsAlessandro Corsaro, Adriana Bajetto, Stefano Thellung, et al.
Oncotarget|November 1, 2014
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion currentMarta Gritti, Roberto Würth, Marina Angelini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
NK cells recognize and kill human glioblastoma cells with stem cell-like propertiesRoberta Castriconi, Antonio Daga, Alessandra Dondero, et al.
Scientific Reports|March 4, 2018
Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor EffectsSara Baldassari, Agnese Solari, Guendalina Zuccari, et al.
Experimental Cell Research|January 7, 2018
In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivityMonica Gatti, Agnese Solari, Alessandra Pattarozzi, et al.
Oncotarget|August 25, 2015
New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALKDaniela Di Paolo, D Yang, Fabio Pastorino, et al.
Oncotarget|December 29, 2016
The inhibition of 45A ncRNA expression reduces tumor formation, affecting tumor nodules compactness and metastatic potential in neuroblastoma cellsIlaria Penna, Arianna Gigoni, Delfina Costa, et al.
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of AktRoberto Würth, Alessandra Pattarozzi, Monica Gatti, et al.
Pageof 8